缺失的Y染色体和人类白血病

A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia.

British journal of haematology·2001

A long-term retrospective study of young women with essential thrombocythemia.

Mayo Clinic proceedings·2001

Anemia after orchiectomy.

American journal of hematology·1998

Treatment of acute myelogenous leukemia in the older patient with attenuated high-dose ara-C.

American journal of clinical oncology·1998

Continuous infusion etoposide/carboplatin for treatment of refractory acute leukemia.

American journal of clinical oncology·1995

Myelodysplastic (preleukemia) syndromes: the bone marrow factory failure problem.

Mayo Clinic proceedings·1995

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Intra-arterial thrombolysis agents following endovascular thrombectomy for acute ischemic stroke: a network meta-analysis.

Frontiers in pharmacology·2026

Lidocaine Versus Amiodarone in Patients With Shockable Out-of-Hospital Cardiac Arrest: A Target Trial Emulation.

Critical care medicine·2026

Combined Left Atrial Appendage Closure and Pulmonary Vein Re-Isolation in Very-High Stroke-Risk Patients.

Pacing and clinical electrophysiology : PACE·2026

Intraoperative Ischemia Threshold and Outcomes of Emergency Vascular Repair During Orthopaedic Arthroplasty: A Time-Critical Analysis from a Dedicated On-Call Vascular Service.

Journal of clinical medicine·2026

Periarticular Embolization as an Alternative Treatment for Surgery-Ineligible Patients with Hip Osteoarthritis: A Prospective Comparative Study.

Journal of clinical medicine·2026

Spontaneous Coronary Artery Dissection, Apical Thrombus and Unknown Hyperthyroidism: A Clinical Case.

Journal of clinical medicine·2026

相关实验视频

缺失的Y染色体和人类白血病

相关概念视频

A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia.

A long-term retrospective study of young women with essential thrombocythemia.

Anemia after orchiectomy.

Treatment of acute myelogenous leukemia in the older patient with attenuated high-dose ara-C.

Continuous infusion etoposide/carboplatin for treatment of refractory acute leukemia.

Myelodysplastic (preleukemia) syndromes: the bone marrow factory failure problem.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Intra-arterial thrombolysis agents following endovascular thrombectomy for acute ischemic stroke: a network meta-analysis.

Lidocaine Versus Amiodarone in Patients With Shockable Out-of-Hospital Cardiac Arrest: A Target Trial Emulation.

Combined Left Atrial Appendage Closure and Pulmonary Vein Re-Isolation in Very-High Stroke-Risk Patients.

Intraoperative Ischemia Threshold and Outcomes of Emergency Vascular Repair During Orthopaedic Arthroplasty: A Time-Critical Analysis from a Dedicated On-Call Vascular Service.

Periarticular Embolization as an Alternative Treatment for Surgery-Ineligible Patients with Hip Osteoarthritis: A Prospective Comparative Study.

Spontaneous Coronary Artery Dissection, Apical Thrombus and Unknown Hyperthyroidism: A Clinical Case.

相关实验视频

缺失的Y染色体和人类白血病

相关概念视频

相关文章